Advertisement
Screener

NOMAD POWER SOLUTIONS, INC. (NMAD) Financing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

NOMAD POWER SOLUTIONS, INC. Financing Cash Flow

NOMAD POWER SOLUTIONS, INC. (NMAD) reported Financing Cash Flow of $17.53 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-14

  • NOMAD POWER SOLUTIONS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $3.84M.
  • NOMAD POWER SOLUTIONS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $5.56M.
  • NOMAD POWER SOLUTIONS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was -$10.00K.
  • NOMAD POWER SOLUTIONS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-03-31 was $914.23K.
  • NOMAD POWER SOLUTIONS, INC. net cash provided by (used in) financing activities for fiscal 2025 was $10.31M.
  • NOMAD POWER SOLUTIONS, INC. net cash provided by (used in) financing activities for fiscal 2023 was $3.14M, a 38.86% decline from fiscal 2022.
  • NOMAD POWER SOLUTIONS, INC. net cash provided by (used in) financing activities for fiscal 2022 was $5.14M, a 31.92% increase from fiscal 2021.
  • NOMAD POWER SOLUTIONS, INC. net cash provided by (used in) financing activities for fiscal 2021 was $3.90M, a 15.31% decline from fiscal 2020.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 monthNet Cash Provided by (Used in) Financing Activities 71 monthNet Cash Provided by (Used in) Financing Activities 74 monthNet Cash Provided by (Used in) Financing Activities 77 monthNet Cash Provided by (Used in) Financing Activities 80 monthNet Cash Provided by (Used in) Financing Activities 83 monthNet Cash Provided by (Used in) Financing Activities 86 monthNet Cash Provided by (Used in) Financing Activities 89 monthNet Cash Provided by (Used in) Financing Activities 92 monthNet Cash Provided by (Used in) Financing Activities 95 monthNet Cash Provided by (Used in) Financing Activities 98 monthNet Cash Provided by (Used in) Financing Activities 101 monthNet Cash Provided by (Used in) Financing Activities 104 month
2026-06-30$17.53M
10-Q · filed 2026-08-14
2025-12-31$3.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$9.41M
derived: sum of 2 quarters · filed 2026-03-31
$9.40M
derived: sum of 3 quarters · filed 2026-08-14
$10.31M
10-K · filed 2026-03-31
2025-09-30$5.56M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12
$5.55M
derived: sum of 2 quarters · filed 2026-08-14
$6.47M
10-Q · filed 2025-11-12
2025-06-30-$10.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$904.23K
10-Q · filed 2026-08-14
2025-03-31$914.23K
10-Q · filed 2026-05-14
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24
$3.14M
derived: sum of 2 quarters · filed 2025-03-24
$3.14M
derived: sum of 3 quarters · filed 2025-03-24
$3.14M
10-K · filed 2025-03-24
2023-09-30$3.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$3.14M
derived: sum of 2 quarters · filed 2024-11-12
$3.14M
10-Q · filed 2024-11-12
$3.14M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$6.28K
10-Q · filed 2024-08-08
$6.28K
derived: sum of 3 quarters · filed 2024-08-08
$6.28K
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$6.28K
10-Q · filed 2024-05-09
$6.28K
derived: sum of 2 quarters · filed 2024-05-09
$6.28K
derived: sum of 3 quarters · filed 2024-05-09
$5.16M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19
$0.00
derived: sum of 2 quarters · filed 2024-03-19
$5.15M
derived: sum of 3 quarters · filed 2024-03-19
$5.14M
10-K · filed 2024-03-19
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$5.15M
derived: sum of 2 quarters · filed 2023-11-09
$5.14M
10-Q · filed 2023-11-09
$5.15M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$5.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$5.14M
10-Q · filed 2023-08-09
$5.15M
derived: sum of 3 quarters · filed 2023-08-09
$5.24M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31-$10.91K
10-Q · filed 2023-05-10
-$906.00
derived: sum of 2 quarters · filed 2023-05-10
$89.09K
derived: sum of 3 quarters · filed 2023-05-10
$190.09K
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$10.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29
$100.00K
derived: sum of 2 quarters · filed 2023-03-29
$201.00K
derived: sum of 3 quarters · filed 2023-03-29
$3.90M
10-K · filed 2023-03-29
2021-09-30$90.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
$191.00K
derived: sum of 2 quarters · filed 2022-11-08
$3.89M
10-Q · filed 2022-11-08
$8.62M
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30$101.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10
$3.80M
10-Q · filed 2022-08-10
$8.53M
derived: sum of 3 quarters · filed 2022-08-10
$8.46M
derived: sum of 4 quarters · filed 2022-08-10
2021-03-31$3.70M
10-Q · filed 2022-05-11
$8.43M
derived: sum of 2 quarters · filed 2022-05-11
$8.35M
derived: sum of 3 quarters · filed 2022-05-11
2020-12-31$4.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21
$4.66M
derived: sum of 2 quarters · filed 2022-03-21
$4.60M
10-K · filed 2022-03-21
2020-09-30-$74.39K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10
-$130.24K
10-Q · filed 2021-11-10
2020-06-30-$55.85K
10-Q · filed 2021-08-10
2018-12-31$4.48M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25
$4.48M
10-K · filed 2020-03-25
2018-09-30$3.00K
10-Q · filed 2019-11-08
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25
$18.00K
derived: sum of 2 quarters · filed 2019-03-25
$1.52M
derived: sum of 3 quarters · filed 2019-03-25
$2.52M
10-K · filed 2019-03-25
2017-09-30$18.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$1.52M
derived: sum of 2 quarters · filed 2018-11-08
$2.52M
10-Q · filed 2018-11-08
$2.52M
derived: sum of 4 quarters · filed 2018-11-08
2017-06-30$1.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
$2.50M
10-Q · filed 2018-08-02
$2.50M
derived: sum of 3 quarters · filed 2018-08-02
$2.50M
derived: sum of 4 quarters · filed 2018-08-02
2017-03-31$1.00M
10-Q · filed 2018-04-27
$1.00M
derived: sum of 2 quarters · filed 2018-04-27
$1.00M
derived: sum of 3 quarters · filed 2018-04-27
$1.58M
derived: sum of 4 quarters · filed 2018-04-27
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23
$0.00
derived: sum of 2 quarters · filed 2018-03-23
$581.33K
derived: sum of 3 quarters · filed 2018-03-23
$1.75M
10-K · filed 2018-03-23
2016-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$581.33K
derived: sum of 2 quarters · filed 2017-11-09
$1.75M
10-Q · filed 2017-11-09
$1.75M
derived: sum of 4 quarters · filed 2017-11-09
2016-06-30$581.33K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04
$1.75M
10-Q · filed 2017-08-04
$1.75M
derived: sum of 3 quarters · filed 2017-08-04
$1.75M
derived: sum of 4 quarters · filed 2017-08-04
2016-03-31$1.17M
10-Q · filed 2017-05-10
$1.17M
derived: sum of 2 quarters · filed 2017-05-10
$1.17M
derived: sum of 3 quarters · filed 2017-05-10
$1.48M
derived: sum of 4 quarters · filed 2017-05-10
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29
$0.00
derived: sum of 2 quarters · filed 2017-03-29
$315.00K
derived: sum of 3 quarters · filed 2017-03-29
$2.05M
10-K · filed 2017-03-29
2015-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04
$315.00K
derived: sum of 2 quarters · filed 2016-11-04
$2.05M
10-Q · filed 2016-11-04
$2.05M
derived: sum of 4 quarters · filed 2016-11-04
2015-06-30$315.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10
$2.05M
10-Q · filed 2016-08-10
$2.05M
derived: sum of 3 quarters · filed 2016-08-10
$2.05M
derived: sum of 4 quarters · filed 2016-08-10
2015-03-31$1.74M
10-Q · filed 2016-05-06
$1.74M
derived: sum of 2 quarters · filed 2016-05-06
$1.74M
derived: sum of 3 quarters · filed 2016-05-06
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28
$0.00
derived: sum of 2 quarters · filed 2016-03-28
$1.41M
10-K · filed 2016-03-28
2014-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10
$1.41M
10-Q · filed 2015-11-10
2014-06-30$1.41M
10-Q · filed 2015-08-07
2014-03-31$7.55M
10-Q · filed 2014-05-09
2013-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21
$0.00
derived: sum of 2 quarters · filed 2014-03-21
$0.00
derived: sum of 3 quarters · filed 2014-03-21
$0.00
10-K · filed 2014-03-21
$7.55M
10-K · filed 2014-03-21
2013-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07
$0.00
derived: sum of 2 quarters · filed 2013-11-07
$0.00
10-Q · filed 2013-11-07
$0.00
derived: sum of 4 quarters · filed 2014-03-21
$7.55M
10-Q · filed 2013-11-07
2013-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05
$0.00
10-Q · filed 2013-08-05
$0.00
derived: sum of 3 quarters · filed 2014-03-21
$0.00
derived: sum of 4 quarters · filed 2014-03-21
$7.55M
10-Q · filed 2013-08-05
2013-03-31$0.00
10-Q · filed 2013-05-09
$0.00
derived: sum of 2 quarters · filed 2014-03-21
$0.00
derived: sum of 3 quarters · filed 2014-03-21
$2.47M
derived: sum of 4 quarters · filed 2014-03-21
$7.55M
10-Q · filed 2013-05-09
2012-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21
$0.00
derived: sum of 2 quarters · filed 2014-03-21
$2.47M
derived: sum of 3 quarters · filed 2014-03-21
$2.50M
10-K · filed 2014-03-21
$7.55M
10-K · filed 2013-03-15
2012-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07
$2.47M
derived: sum of 2 quarters · filed 2013-11-07
$2.50M
10-Q · filed 2013-11-07
$2.50M
derived: sum of 4 quarters · filed 2013-11-07
$7.55M
10-Q · filed 2012-11-13
2012-06-30$2.47M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-05
$2.50M
10-Q · filed 2013-08-05
$2.50M
derived: sum of 3 quarters · filed 2013-08-05
$2.50M
derived: sum of 4 quarters · filed 2013-08-05
$7.55M
10-Q · filed 2012-08-10
2012-03-31$33.33K
10-Q · filed 2013-05-09
$33.33K
derived: sum of 2 quarters · filed 2013-05-09
$33.33K
derived: sum of 3 quarters · filed 2013-05-09
$38.33K
derived: sum of 4 quarters · filed 2013-05-09
$5.08M
10-Q · filed 2012-05-10
2011-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15
$0.00
derived: sum of 2 quarters · filed 2013-03-15
$5.00K
derived: sum of 3 quarters · filed 2013-03-15
$5.00K
10-K · filed 2013-03-15
$5.05M
10-K · filed 2012-03-29
2011-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13
$5.00K
derived: sum of 2 quarters · filed 2012-11-13
$5.00K
10-Q · filed 2012-11-13
$5.00K
derived: sum of 4 quarters · filed 2012-11-13
$5.05M
10-Q · filed 2011-11-10
2011-06-30$5.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10
$5.00K
10-Q · filed 2012-08-10
$5.00K
derived: sum of 3 quarters · filed 2012-08-10
$5.00K
derived: sum of 4 quarters · filed 2012-08-10
$5.05M
10-Q · filed 2011-08-12
2011-03-31$0.00
10-Q · filed 2012-05-10
$0.00
derived: sum of 2 quarters · filed 2012-05-10
$0.00
derived: sum of 3 quarters · filed 2012-05-10
2010-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29
$0.00
derived: sum of 2 quarters · filed 2012-03-29
$1.09M
10-K · filed 2012-03-29
2010-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10
$1.09M
10-Q · filed 2011-11-10
2010-06-30$1.09M
10-Q · filed 2011-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
TALPHERA, INC. (TLPH)United States$0.060B
CalciMedica, Inc. (CALC)United States$0.061B-1.42
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
HERON THERAPEUTICS, INC. /DE/ (HRTX)United States$0.055B-2.38
Clene Inc. (CLNN)United States$0.054B-1.99
Serina Therapeutics, Inc. (SER)United States$0.054B-2.35
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
Xilio Therapeutics, Inc. (XLO)United States$0.052B